Author:
Kalle Arunasree M.,Rizvi Arshad
Abstract
ABSTRACTMultidrug resistance (MDR) is a major problem in the treatment of infectious diseases and cancer. Accumulating evidence suggests that the cyclooxygenase-2 (COX-2)-specific inhibitor celecoxib would not only inhibit COX-2 but also help in the reversal of drug resistance in cancers by inhibiting the MDR1 efflux pump. Here, we demonstrate that celecoxib increases the sensitivity of bacteria to the antibiotics ampicillin, kanamycin, chloramphenicol, and ciprofloxacin by accumulating the drugs inside the cell, thus reversing MDR in bacteria.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference16 articles.
1. Arunasree, K. M., K. R. Roy, K. Anilkumar, A. Aparna, G. V. Reddy, and P. Reddanna. 2008. Imatinib-resistant K562 cells are more sensitive to celecoxib, a selective COX-2 inhibitor: role of COX-2 and MDR-1. Leuk. Res. 32:855-864.
2. Danilchanka, O., C. Mailaender, and M. Niederweis. 2008. Identification of a novel multidrug efflux pump of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 52:2503-2511.
3. Gupta, A. K., D. S. Chauhan, K. Srivastava, R. Das, S. Batra, M. Mittal, P. Goswami, N. Singhal, V. D. Sharma, K. Venkatesan, S. E. Hasnain, and V. M. Katoch. 2006. Estimation of efflux mediated multi-drug resistance and its correlation with expression levels of two major efflux pumps in mycobacteria. J. Commun. Dis. 38:246-254.
4. Kalle, A. M., S. Sachchidanand, and R. Pallu. 2010. Bcr-Abl-independent mechanism of resistance to imatinib in K562 cells: induction of cyclooxygenase-2 (COX-2) by histone deacetylases (HDACs). Leuk. Res. 34:1132-1138.
5. Kern, W. V., P. Steinke, A. Schumacher, S. Schuster, H. von Baum, and J. A. Bohnert. 2006. Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Escherichia coli. J. Antimicrob. Chemother. 57:339-343.
Cited by
70 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献